Form 4: Codexis Director Sells Shares Under 10b5-1 Plan

A director at Codexis, Dennis P. Wolf, sold 8,952 shares of common stock for a weighted average price of $1.5626 per share under a pre-arranged trading plan.

Summary

• Dennis P. Wolf, a Director of Codexis, Inc. (CDXS), reported a sale of common stock.
• The transaction involved the disposition of 8,952 shares of common stock.
• The shares were sold on 11/21/2025 at a weighted average price of $1.5626 per share.
• The sale was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Following this transaction, Mr. Wolf beneficially owns 138,951 shares of Codexis common stock, which includes 40,983 restricted stock units.
• The sale price ranged from $1.55 to $1.615 per share across multiple trades.

Sentiment

Score: 5

Explanation: A neutral score. While an insider sale can be seen negatively, the transaction was pre-planned under a 10b5-1 plan, which mitigates the immediate negative signal. It's a routine disclosure for a director managing their personal holdings.

Positives

• The sale was conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction rather than an immediate reaction to new information.

Negatives

• A director selling shares can sometimes be perceived negatively by the market, as it reduces their direct stake in the company.

Risks

• Potential negative market perception due to insider selling, even if pre-planned.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or relate to overall industry trends. Insider sales, even under 10b5-1 plans, are routinely monitored by investors for sentiment.

Stakeholder Impact

• Shareholders: May interpret the director's sale as a slight negative signal, though mitigated by the 10b5-1 plan.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-planned insider sale by a director. While insider sales are generally monitored, the transaction was executed under a Rule 10b5-1 plan, suggesting it was not based on new, material non-public information. The sale amount is not exceptionally large relative to the director's remaining holdings or the company's market capitalization. Therefore, this specific filing alone does not provide sufficient new information to warrant a change in investment thesis, leading to a 'hold' recommendation.

Keywords

Codexis, CDXS, Insider Sale, Form 4, Dennis Wolf, Stock Transaction, 10b5-1 Plan, Director Sale